Travere Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
TVTX Nasdaq 2830 www.travere.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Travere Therapeutics, Inc.

Travere Therapeutics to Report Third Quarter 2026 Financial Results - Oct 26th, 2026 2:30 pm
Travere Presents New Biomarker Data at ASN Kidney Week Suggesting FILSPARI® (sparsentan) May Modify Underlying Disease Pathophysiology in IgA Nephropathy - Oct 23rd, 2026 5:20 pm
AstraZeneca Gets Accelerated FDA Nod for Ultomiris in IgA Nephropathy - Oct 22nd, 2026 8:27 am
Earnings Preview: Travere Therapeutics (TVTX) Q3 Earnings Expected to Decline - Oct 22nd, 2026 7:00 am
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Oct 12th, 2026 3:00 pm
Travere Therapeutics (TVTX) Is Down 6.7% After New FILSPARI Data And Patent Extension - What's Changed - Oct 7th, 2026 12:10 am
Travere to Present New Data Supporting FILSPARI® (sparsentan) as Foundational Treatment in IgA Nephropathy and FSGS at ASN Kidney Week 2026 - Oct 2nd, 2026 8:00 am
Travere Therapeutics Receives Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Directed to Certain Methods of Using FILSPARI® (sparsentan) in Focal Segmental Glomerulosclerosis - Sep 23rd, 2026 5:00 am
Travere Therapeutics (TVTX) Sets CEO Handover For December 2026 - Sep 22nd, 2026 7:13 pm
Travere Therapeutics (TVTX) Stock May Trade Above Fair Value Today - Sep 22nd, 2026 8:13 am
Travere Therapeutics Announces Planned Chief Executive Officer Transition - Sep 21st, 2026 2:05 pm
Travere Therapeutics to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum - Sep 17th, 2026 2:30 pm
Travere Therapeutics' Outlook Brightens As Turnaround Looms - Sep 8th, 2026 1:44 pm
TGTX Stock Outperforms 95% of Stocks. Here's Why. - Aug 24th, 2026 10:56 am
IBD Stock Of The Day, Travere Therapeutics, Tests Another Breakout. Can The Stock Get Any 'Sweeter?' - Aug 21st, 2026 11:09 am
Three Biotech Stocks Stick Out With Their Stellar Charts - Aug 21st, 2026 10:09 am
Travere Therapeutics Sees FILSPARI FSGS Launch Top Expectations, Expands Renal Pipeline - Aug 18th, 2026 4:01 am
Travere Therapeutics (TVTX) Q2 2026 Earnings Call Transcript - Aug 11th, 2026 6:13 pm